“…In patients with soft tissue sarcoma of the extremity, two small randomized trials have shown that postoperatiive external beam radiotherapy or brachytherapy improve local control, but do not benefit overall survival ( 115 – 117 ). In retroperitoneal soft tissue sarcoma, a myriad of small trials has been published, which show marked variation in RT dose, fractionation, concurrent use of chemotherapy, delivery method (external beam or brachytherapy), timing (preoperative, intraoperative, or postoperative), and energy carrier (photons, electrons, protons, or carbon ions) ( 118 ).…”